EC grants marketing authorisation to BridgeBio’s Beyonttra
The therapy has demonstrated significant benefits in cardiovascular outcomes. Credit: Jo Panuwat D/Shutterstock. The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective